Wall St Warrior

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

By Rishika Sadam HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world’s most populous country grappling with increasing rates of obesity and diabetes. U.S.-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative…

Read More

GM to use Nvidia AI chips, software to automate vehicles, factories

By Kalea Hall and Abhirup Roy (Reuters) – General Motors will use artificial intelligence chips and software from Nvidia to develop autonomous vehicle technology for its vehicles and improve workflow at its factories, the companies said on Tuesday. Traditional automakers have struggled to commercialize autonomous technology that has been more challenging and expensive than expected…

Read More

Explainer-Event contracts: Trading’s next big thing or ‘backdoor to gambling’?

(Reuters) -Event contracts have exploded in popularity since the U.S. presidential election, fueling a heated debate between traders who have embraced the nascent asset class and critics who liken it to gambling. Several market players such as retail-favorite Robinhood and Interactive Brokers have rolled out event contracts in recent months, looking to cash in on…

Read More